{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:44:11Z","timestamp":1791639851500,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.radonc.2024.110222","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T08:24:14Z","timestamp":1710145454000},"page":"110222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Dosimetric impact of bone marrow sparing for robustly optimized IMPT for locally advanced cervical cancer"],"prefix":"10.1016","volume":"195","author":[{"given":"S.C.","family":"Kuipers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Godart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Corbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Breedveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.M.","family":"Mens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Hoogeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110222_b0005","first-page":"1","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer\u2013Update","volume":"2023","author":"Cibula","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.radonc.2024.110222_b0010","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2018-000057","article-title":"Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer","volume":"29","author":"Horeweg","year":"2019","journal-title":"International Journal of Gynecologic Cancer"},{"key":"10.1016\/j.radonc.2024.110222_b0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.radonc.2021.10.015","article-title":"Pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis","volume":"165","author":"Zhou","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-020-01606-3","article-title":"Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial","volume":"15","author":"Huang","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0030","first-page":"936","article-title":"The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis. International Journal of Radiation Oncology* Biology*","volume":"111","author":"Damen","year":"2021","journal-title":"Physics"},{"key":"10.1016\/j.radonc.2024.110222_b0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2015.11.013","article-title":"Lymphopenia and its association with survival in patients with locally advanced cervical cancer","volume":"140","author":"Wu","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1088\/0031-9155\/5\/3\/302","article-title":"The distribution of active bone marrow in the adult","volume":"5","author":"Ellis","year":"1961","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2024.110222_b0045","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2009.11.040","article-title":"Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging","volume":"79","author":"Hayman","year":"2011","journal-title":"International Journal of Radiation Oncology* Biology* Physics"},{"key":"10.1016\/j.radonc.2024.110222_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2021.09.009","article-title":"Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review","author":"Corbeau","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.radonc.2016.06.016","article-title":"Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy?","volume":"120","author":"van de Sande","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-015-0402-z","volume":"10","author":"Marnitz","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.radonc.2020.09.022","article-title":"Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer","volume":"154","author":"Gort","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1120\/jacmp.v11i4.3255","article-title":"Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer","volume":"11","author":"Song","year":"2010","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2024.110222_b0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.radonc.2015.05.005","article-title":"Bone marrow sparing in intensity modulated proton therapy for cervical cancer: Efficacy and robustness under range and setup uncertainties","volume":"115","author":"Dinges","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-022-02175-3","article-title":"Dosimetric evaluation of bone marrow sparing in proton radiotherapy for cervical cancer guided by MR functional imaging","volume":"17","author":"Qin","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0085","doi-asserted-by":"crossref","DOI":"10.1097\/IGC.0000000000001312","article-title":"The effect of body mass index and weight change on late gastrointestinal toxicity in locally advanced cervical cancer treated with intensity-modulated radiotherapy","volume":"28","author":"Lee","year":"2018","journal-title":"International Journal of Gynecologic Cancer"},{"key":"10.1016\/j.radonc.2024.110222_b0090","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00066-021-01781-6","article-title":"Early morbidity and dose\u2013volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques","volume":"197","author":"Seppenwoolde","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2024.110222_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109501","article-title":"Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors","volume":"181","author":"Spampinato","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1138433","article-title":"The impact of bone marrow sparing on organs at risk dose for cervical cancer: a Pareto front analysis","volume":"13","author":"Kuipers","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0105","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.3390\/cancers13205179","article-title":"PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System","volume":"13","author":"Corbeau","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2024.110222_b0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ctro.2018.01.001","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clinical and translational radiation oncology"},{"key":"10.1016\/j.radonc.2024.110222_b0115","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.radonc.2015.08.034","article-title":"Quantification of intra-fraction changes during radiotherapy of cervical cancer assessed with pre-and post-fraction Cone Beam CT scans","volume":"117","author":"Heijkoop","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0120","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy","volume":"66","author":"Mell","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110222_b0125","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.ijrobp.2011.10.011","article-title":"Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans","volume":"83","author":"Bondar","year":"2012","journal-title":"International Journal of Radiation Oncology* Biology* Physics"},{"key":"10.1016\/j.radonc.2024.110222_b0130","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1118\/1.3676689","article-title":"iCycle: Integrated, multicriterial beam angle, and profile optimization for generation of coplanar and noncoplanar IMRT plans","volume":"39","author":"Breedveld","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110222_b0135","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1088\/0031-9155\/58\/19\/6969","article-title":"Improved efficiency of multi-criteria IMPT treatment planning using iterative resampling of randomly placed pencil beams","volume":"58","author":"van de Water","year":"2013","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2024.110222_b0140","first-page":"624","article-title":"A case study in proton pencil-beam scanning delivery. International Journal of Radiation Oncology* Biology*","volume":"76","author":"Kooy","year":"2010","journal-title":"Physics"},{"key":"10.1016\/j.radonc.2024.110222_b0145","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1088\/0031-9155\/61\/4\/1780","article-title":"Beam configuration selection for robust intensity-modulated proton therapy in cervical cancer using Pareto front comparison","volume":"61","author":"Van De Schoot","year":"2016","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2024.110222_b0150","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1088\/0031-9155\/52\/10\/009","article-title":"Accounting for range uncertainties in the optimization of intensity modulated proton therapy","volume":"52","author":"Unkelbach","year":"2007","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2024.110222_b0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2019.08.005","article-title":"Practical robustness evaluation in radiotherapy\u2013A photon and proton-proof alternative to PTV-based plan evaluation","volume":"141","author":"Korevaar","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0160","first-page":"630","article-title":"Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study. International Journal of Radiation Oncology* Biology*","volume":"88","author":"Chopra","year":"2014","journal-title":"Physics"},{"key":"10.1016\/j.radonc.2024.110222_b0165","first-page":"13","article-title":"Early toxicity and treatment outcomes of extended field-intensity modulated radiotherapy for cervical cancer patients with para-aortic nodal metastasis","author":"Gupta","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.radonc.2024.110222_b0170","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.2147\/CMAR.S195989","article-title":"Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation","volume":"11","author":"Kumar","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.radonc.2024.110222_b0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2020.09.033","article-title":"Radiotherapy Treatment plannINg study Guidelines (RATING): A framework for setting up and reporting on scientific treatment planning studies","volume":"153","author":"Hansen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0180","article-title":"Concomitant cisplatin and extended field radiation therapy in patients with cervical and endometrial cancer. International Journal of Gynecologic","volume":"12","author":"Sood","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110222_b0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/gyno.2000.6109","article-title":"Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer","volume":"81","author":"Abu-Rustum","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2024.110222_b0195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2017.11.028","article-title":"Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy","volume":"128","author":"Shiraishi","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0200","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/neuonc\/noaa182","article-title":"Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons","volume":"23","author":"Mohan","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110019","article-title":"Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy","volume":"190","author":"Cortiula","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110222_b0210","article-title":"Severe lymphopenia during chemoradiation therapy for esophageal cancer: Comprehensive analysis of randomized phase 2B trial of proton beam therapy versus intensity modulated radiation therapy","author":"Wang","year":"2023","journal-title":"International Journal of Radiation Oncology* Biology* Physics"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024001440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024001440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T17:38:24Z","timestamp":1741455504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024001440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":42,"alternative-id":["S0167814024001440"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110222","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric impact of bone marrow sparing for robustly optimized IMPT for locally advanced cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110222"}}